Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. APEO.L Share Price
  4. APEO.L Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksAPEO.L Regulatory News (APEO)

APEO.L Information
  • There is currently no data for APEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

5 Feb 2024 07:00

RNS Number : 9250B
abrdn Private Equity Opp Trst plc
05 February 2024
 

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

5 February 2024

 

PURCHASE OF OWN SHARES

 

On 2 February 2024, abrdn Private Equity Opportunities Trust plc ("APEO") bought back 194,317 Ordinary Shares at an average price of 500.35 pence per share to be held in Treasury.

 

Following the transaction, APEO's issued ordinary share capital comprises:

 

· 153,551,977 Issued Ordinary shares (excluding treasury shares)

· 194,317 Ordinary shares held in Treasury

· 153,746,294 Issued Ordinary shares (including treasury shares)

 

The total number of voting rights in APEO is 153,551,977. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in APEO, under the Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

Paul Evitt

abrdn Holdings Limited

Company Secretary

 

Tel. 0131 372 9371

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUURBRSRUURAR
123
Date   Source Headline
9th Jun 20237:00 amRNSNotice of Results
17th May 202311:51 amRNSHolding(s) in Company
17th May 20237:00 amRNSEstimate NAV at 30 April 2023
25th Apr 202311:52 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNSEstimated NAV at 31 March 2023
11th Apr 202311:23 amRNSQuarterly disclosure
22nd Mar 20231:41 pmRNSResult of AGM
16th Mar 20237:00 amRNSEstimated NAV at 28 February 2023
9th Mar 20237:00 amRNSFirst Interim Dividend
14th Feb 20237:00 amRNSEstimated NAV at 31 January 2023
10th Feb 20238:57 amRNSDoc re. Annual Financial Report
9th Feb 20234:40 pmRNSSecond Price Monitoring Extn
9th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 202311:38 amRNSDirector/PDMR Shareholding
31st Jan 202310:49 amRNSAnnual Financial Report
31st Jan 20237:00 amRNSAnnual Financial Report
18th Jan 20232:10 pmRNSNotice of Results
18th Jan 20237:00 amRNSEstimated NAV at 31 December 2022
9th Jan 20238:51 amRNSQuarterly disclosure
15th Dec 20227:00 amRNSEstimated NAV at 30 November 2022
13th Dec 20223:18 pmRNSFourth Interim Dividend Announcement
28th Nov 20227:01 amRNSCompany Secretary - Change of Name
21st Nov 20224:36 pmRNSPrice Monitoring Extension
14th Nov 20227:00 amRNSEstimated NAV at 31 October 2022
2nd Nov 20222:13 pmRNSDirector/PDMR Shareholding
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:36 pmRNSPrice Monitoring Extension
28th Oct 20229:42 amRNSEdison update on abrdn Private Equity Opp Trst
24th Oct 20224:41 pmRNSSecond Price Monitoring Extn
24th Oct 20224:36 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSEstimated NAV at 30 September 2022
10th Oct 20227:00 amRNSIncrease of Loan Facility
7th Oct 202210:33 amRNSQuarterly disclosure
16th Sep 20224:35 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSEstimated NAV at 31 August 2022
9th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20224:36 pmRNSResearch from QuotedData
8th Sep 202211:21 amRNSDirector/PDMR Shareholding
8th Sep 202210:11 amRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSThird Interim Dividend
12th Aug 20227:00 amRNSEstimated NAV at 31 July 2022
10th Aug 20225:49 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSEdison issues review on Abrdn Private Equity Opp.
21st Jul 20224:35 pmRNSPrice Monitoring Extension
14th Jul 202210:26 amRNSDoc re. Half Yearly Report
14th Jul 20227:00 amRNSEstimated NAV at 30 June 2022
5th Jul 20222:18 pmRNSQuarterly disclosure
30th Jun 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSHalf-year Report
16th Jun 20227:00 amRNSEstimated NAV at 31 May 2022
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.